CD8A and cancer: It is well known that CD8 T cells, NK cells, and Th1 cells exert anticancer immunity, while TAMs, MDSCs, Tregs, Th2 cells, and tolerogenic mDCs foster pro-cancer immune escape in the TIME (Zhang and Zhang, 2020; Saillard et al., 2021).